Condition: Chronic Lymphocytic Leukemia · Non-Hodgkin Lymphoma · Sponsor: Eli Lilly and Company
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib. The clinical studies that will feed into this master protocol are referred to as originator studies. The master protocol will govern individual study-specific appendices (ISAs) that will represent participants from the individual, completed originator studies. These participants will have the opportunity to enter this study and continue to receive treatment or continue follow-up visits. Overall, the master protocol and the individual ISAs, when combined, define the investigations for this study.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Cancer Specialists, LLC | Jacksonville, Florida, United States | Not Yet Recruiting |
| Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
| Florida Cancer Specialists | Sarasota, Florida, United States | Recruiting |
| The Emory Clinic | Atlanta, Georgia, United States | Not Yet Recruiting |
| Northwestern University | Chicago, Illinois, United States | Not Yet Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic- Minnesota | Rochester, Minnesota, United States | Recruiting |
| University Of Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
| Cayuga Cancer Center | Ithaca, New York, United States | Recruiting |
| Northwell Health | Lake Success, New York, United States | Recruiting |
| Memorial Sloan-Kettering Cancer Center (MSKCC) - New York | New York, New York, United States | Recruiting |
| Memorial Sloan-Kettering Cancer Center (MSKCC) - New York | New York, New York, United States | Not Yet Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06876649